Latest Mitral valve Stories

2011-08-17 06:28:00

TSX Venture Exchange: NVC --Will Fund New Initiative to Treat Mitral Valve Disease and Completion of COSIRA Trial Designed to Support Marketing Approval of Neovasc Reducer(TM) for Treatment of Refractory Angina-- VANCOUVER, Aug. 17, 2011 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that it has completed a previously announced non-brokered private placement of 4,720,500 equity units at the price of $1.00 per unit for aggregate gross proceeds of approximately $4,720,500....

2011-08-09 09:28:50

A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition. An estimated 1.6 million Americans suffer moderate to severe leakage through their tricuspid valve, a complex structure that closes off the heart's right ventricle from the right atrium. Most people have at least some leakage in the valve, but what causes the problem is not well understood. A new study, published online in the journal...

2011-07-21 06:32:00

--Proceeds Will be Used To Fund New Initiative to Treat Mitral Valve Disease and to Complete Neovasc Reducer(TM) COSIRA Trial for Treating Refractory Angina-- TSX Venture Exchange: NVC VANCOUVER, July 21, 2011 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that it intends to complete a non-brokered private placement with accredited investors of up to four million equity units at the price of $1.00 per unit for aggregate gross proceeds of up to $4.0 million. The company...

2011-06-24 23:06:56

 An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery. "This breakthrough technology could save the lives of thousands of patients with heart valve disease who have no other therapeutic options," says Dr. Ziyad Hijazi, director of the Rush Center for Congenital and...

2011-05-25 09:19:00

ST. LOUIS, May 25, 2011 /PRNewswire/ -- Missouri Baptist Medical Center cardiac surgeons and cardiologists are teaming up to provide better treatment options for patients with heart valve conditions. The new Heart Valve Clinic at Missouri Baptist opens June 3, offering patients with heart valve disease access to several specialists at one time in order to expedite their care and help determine the optimal treatment protocol in a setting that is convenient for the patient. "Valve...

2011-05-04 05:00:00

KIRKLAND, Wash., May 4, 2011 /PRNewswire/ -- Cardiac Dimensions®, Inc. announced today the initiation of two new clinical studies using the CARILLON® Mitral Contour System(TM), an investigational device for percutaneous treatment of Functional Mitral Regurgitation (FMR). The CARILLON system is a minimally invasive device designed to repair the heart's mitral valve and reduce FMR, a disorder that affects most of the estimated 5 million people in the U.S....

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.